cyc 202 has been researched along with pyrroles in 8 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (pyrroles) | Trials (pyrroles) | Recent Studies (post-2010) (pyrroles) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 26,129 | 2,815 | 12,100 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elbaum, D; Lydon, NB; Toledo, LM | 1 |
| Borysko, KZ; Breitenbach, JM; Drach, JC; Evers, DL; Townsend, LB | 1 |
| Brady, HJ; Caldicott, A; Crescenzi, E; Dransfield, I; Duffin, R; Gray, M; Haslett, C; Martin, MC; Martinez-Losa, M; Riley, NA; Rossi, AG; Savill, JS; Sawatzky, DA; Sheldrake, TA; Walker, A; Walker, TR; Ward, C | 1 |
| Bareford, MD; Dent, P; Eulitt, P; Hossein, H; Martin, AP; Mitchell, C; Nephew, KP; Yacoub, A; Yang, C | 1 |
| Cai, J; Hong, Y; Imperato-McGinley, J; Tan, C; Weng, C; Zhu, YS | 1 |
| Bai, XG; He, HW; Li, XM; Shao, RG; Wang, JX; Wang, YC; Yu, DK; Zhang, H | 1 |
| Crews, LA; Gonzales, T; Kouznetsova, VL; Masliah, E; Overk, CR; Patrick, C; Paulino, A; Price, D; Rockenstein, E; Stocking, E; Tsigelny, IF; Wrasidlo, W | 1 |
| Arang, N; Bello, T; Dudgeon, DR; Glennon, EK; Gujral, TS; Kain, HS; Kaushansky, A; Walter, ENF | 1 |
1 review(s) available for cyc 202 and pyrroles
| Article | Year |
|---|---|
The structure-based design of ATP-site directed protein kinase inhibitors.
Topics: Adenosine Triphosphate; Adenylyl Imidodiphosphate; Anthraquinones; Binding Sites; Catalytic Domain; Cyclin-Dependent Kinases; Drug Design; Enzyme Inhibitors; Humans; Kinetin; Piperazines; Protein-Tyrosine Kinases; Purines; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Receptors, Growth Factor; Roscovitine; Staurosporine; Structure-Activity Relationship | 1999 |
7 other study(ies) available for cyc 202 and pyrroles
| Article | Year |
|---|---|
Inhibition of cyclin-dependent kinase 1 by purines and pyrrolo[2,3-d]pyrimidines does not correlate with antiviral activity.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; CDC2 Protein Kinase; Cell Division; Cell Survival; Chlorocebus aethiops; Cyclin B; Cytomegalovirus; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Herpesvirus 1, Human; Purines; Pyrimidines; Pyrroles; Roscovitine; Structure-Activity Relationship; Vero Cells; Viral Plaque Assay | 2002 |
Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis.
Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Azepines; Carrageenan; Caspase 3; Cyclin-Dependent Kinases; Enzyme Inhibitors; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Inflammation; Male; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Neutrophils; Pleurisy; Proto-Oncogene Proteins c-bcl-2; Purines; Pyrroles; Roscovitine | 2006 |
Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Blotting, Western; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cyclin-Dependent Kinases; Drug Synergism; Electrophoresis, Polyacrylamide Gel; ErbB Receptors; Female; Flavonoids; Fluorescent Antibody Technique; Gene Knockout Techniques; Humans; Indoles; Lapatinib; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Molecular Targeted Therapy; Myeloid Cell Leukemia Sequence 1 Protein; Piperidines; Proto-Oncogene Proteins c-bcl-2; Purines; Pyrroles; Quinazolines; Roscovitine | 2010 |
Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism.
Topics: Androgen Receptor Antagonists; Anilides; Aorta; Cell Proliferation; Cells, Cultured; Cyclin A; Dihydrotestosterone; DNA; Endothelium, Vascular; Estradiol; Gene Expression; Humans; Indoles; Male; Nitriles; Protein Kinase Inhibitors; Purines; Pyrroles; Receptors, Androgen; Roscovitine; Testosterone; Tosyl Compounds; Vascular Endothelial Growth Factor A | 2011 |
Design, synthesis and anticancer activity of 1-acyl-3-amino-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole derivatives.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cyclin-Dependent Kinase 5; Drug Design; Drug Screening Assays, Antitumor; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HCT116 Cells; Humans; Molecular Docking Simulation; Protein Kinases; Protein Structure, Tertiary; Purines; Pyrazoles; Pyrroles; Roscovitine; Structure-Activity Relationship | 2012 |
Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders.
Topics: AIDS Dementia Complex; Animals; Antineoplastic Agents; Cyclin-Dependent Kinase 5; Dasatinib; Erlotinib Hydrochloride; Flavonoids; HIV Envelope Protein gp120; In Vitro Techniques; Indoles; Lapatinib; Mice; Mice, Transgenic; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Protein Kinase Inhibitors; Purines; Pyrimidines; Pyrroles; Quinazolines; Rats; Roscovitine; Sunitinib; Thiazoles | 2014 |
Identifying host regulators and inhibitors of liver stage malaria infection using kinase activity profiles.
Topics: Animals; Cell Line, Tumor; HEK293 Cells; Hepatocytes; Host-Parasite Interactions; Humans; Indoles; Liver; Malaria; Mice; Piperazines; Plasmodium yoelii; Protein Kinase Inhibitors; Protein Kinases; Purines; Pyrroles; RNA Interference; Roscovitine; Sporozoites; Sunitinib | 2017 |